Article info
Multiple sclerosis
Research paper
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
- Correspondence to Dr M H Soilu-Hänninen, University Hospital of Turku, Department of Neurology, Kiinamyllynkatu 4-8, Turku FIN-20520, Finland; mersoi{at}utu.fi
Citation
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
Publication history
- Received November 24, 2011
- Revised January 28, 2012
- Accepted January 30, 2012
- First published February 22, 2012.
Online issue publication
April 03, 2012
Article Versions
- Previous version (22 February 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.